Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 2
2013 1
2014 2
2015 1
2017 2
2018 2
2019 10
2020 9
2021 11
2022 6
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Biosimilars vs originators: Are they the same?
Sarzi-Puttini P, Marotto D, Caporali R, Galeazzi M, Atzeni F, Hamar A, Soós B, Szekanecz Z. Sarzi-Puttini P, et al. Among authors: soos b. Autoimmun Rev. 2019 Dec;18(12):102404. doi: 10.1016/j.autrev.2019.102404. Epub 2019 Oct 19. Autoimmun Rev. 2019. PMID: 31639517 Review.
Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases.
Szekanecz Z, Gomez I, Soós B, Bodoki L, Szamosi S, András C, Juhász B, Váróczy L, Antal-Szalmás P, Szodoray P, Bittner N, Árkosy P, Illés Á, Szűcs G, Dankó K, Bender T, Tamási L, Szekanecz É; Hungarian OncoRheumatology Network (HORN) initiative. Szekanecz Z, et al. Among authors: soos b. Autoimmun Rev. 2020 Nov;19(11):102658. doi: 10.1016/j.autrev.2020.102658. Epub 2020 Sep 14. Autoimmun Rev. 2020. PMID: 32942035 Free article. Review.
Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis.
Czókolyová M, Hamar A, Pusztai A, Tajti G, Végh E, Pethő Z, Bodnár N, Horváth Á, Soós B, Szamosi S, Szentpéteri A, Seres I, Harangi M, Paragh G, Kerekes G, Bodoki L, Domján A, Hodosi K, Seres T, Panyi G, Szekanecz Z, Szűcs G. Czókolyová M, et al. Among authors: soos b. Biomolecules. 2022 Oct 14;12(10):1483. doi: 10.3390/biom12101483. Biomolecules. 2022. PMID: 36291691 Free PMC article.
[Oncorheumatology: relationship between malignancies and musculoskeletal diseases].
Szekanecz Z, Gomez I, Soós B, Bodoki L, Szamosi S, András C, Juhász B, Váróczy L, Antal-Szalmás P, Szodoray P, Bittner N, Árkosy P, Illés Á, Szűcs G, Dankó K, Bender T, Tamási L, Szekanecz É. Szekanecz Z, et al. Among authors: soos b. Orv Hetil. 2020 Jul;161(28):1151-1165. doi: 10.1556/650.2020.31800. Orv Hetil. 2020. PMID: 32609623 Hungarian.
Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.
Soós B, Fagyas M, Horváth Á, Végh E, Pusztai A, Czókolyová M, Csongrádi A, Hamar A, Pethő Z, Bodnár N, Kerekes G, Hodosi K, Szekanecz É, Szamosi S, Szántó S, Szűcs G, Papp Z, Szekanecz Z. Soós B, et al. Front Med (Lausanne). 2022 Jan 27;8:785744. doi: 10.3389/fmed.2021.785744. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35155468 Free PMC article.
Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.
Kerekes G, Czókolyová M, Hamar A, Pusztai A, Tajti G, Katkó M, Végh E, Pethő Z, Bodnár N, Horváth Á, Soós B, Szamosi S, Hascsi Z, Harangi M, Hodosi K, Panyi G, Seres T, Szűcs G, Szekanecz Z. Kerekes G, et al. Among authors: soos b. Rheumatology (Oxford). 2023 Oct 23;62(SI3):SI304-SI312. doi: 10.1093/rheumatology/kead502. Rheumatology (Oxford). 2023. PMID: 37871914 Free PMC article.
55 results